The Comparison of Remimazolam With Propofol in Core Body Temperature

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

November 30, 2021

Conditions
Hypothermia; Anesthesia
Interventions
DRUG

Remifentanil

"1. Remimazolm and Remifentanil (RR group): anesthesia was induced with remimazolam 6 mg/kg/h by continuous intravenous (IV) infusion and with the effect-site concentration of remifentanil 4 ng/ml and until the loss of consciousness (LoC), followed by remimazolam 1-2 mg/kg/h and remifentanil 3 ng/ml until the end of surgery.~2. Propofol and Remifentanil (PR group), anesthesia was induced with the effect-site concentration of propofol of 6.0 μg/ml and remifentanil 4 ng/ml, and until the loss of consciousness (LoC), followed by the effect-site concentration of propofol of 2-4 μg/ml and remifentanil 3 ng/ml until the end of surgery."

Trial Locations (1)

54538

Wonkwag UH, Iksan

All Listed Sponsors
lead

Wonkwang University Hospital

OTHER

NCT05215834 - The Comparison of Remimazolam With Propofol in Core Body Temperature | Biotech Hunter | Biotech Hunter